Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR
Report ID | 225212 |
Drug Identification Number | 02261847 |
Brand name | SANDOZ-CARBAMAZEPINE CR |
Common or Proper name | CARBAMAZEPINE CR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100MRT |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-15 |
Estimated end date | 2024-08-30 |
Actual end date | 2024-07-02 |
Shortage status | Resolved |
Updated date | 2025-03-12 |
Company comments | Product available under allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v28 | 2025-03-12 | English | Compare |
v27 | 2024-07-03 | English | Compare |
v26 | 2024-07-02 | French | Compare |
v25 | 2024-07-02 | English | Compare |
v24 | 2024-06-25 | French | Compare |
v23 | 2024-06-25 | English | Compare |
v22 | 2024-06-25 | French | Compare |
v21 | 2024-06-25 | English | Compare |
v20 | 2024-06-25 | French | Compare |
v19 | 2024-06-25 | English | Compare |
v18 | 2024-06-25 | English | Compare |
v17 | 2024-06-25 | French | Compare |
v16 | 2024-06-25 | French | Compare |
v15 | 2024-06-25 | English | Compare |
v14 | 2024-06-25 | French | Compare |
v13 | 2024-06-25 | English | Compare |
v12 | 2024-06-18 | French | Compare |
v11 | 2024-06-18 | English | Compare |
v10 | 2024-06-17 | French | Compare |
v9 | 2024-06-17 | English | Compare |